- Home
- BIO vs LLYVA Comparison
BIO vs LLYVA Comparison
Compare BIO & LLYVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BIO | LLYVA |
|---|---|---|
| Founded | 1952 | 1991 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Broadcasting |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7B | 7.0B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BIO | LLYVA |
|---|---|---|
| Price | $322.33 | $81.98 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $358.50 | N/A |
| AVG Volume (30 Days) | 184.0K | ★ 211.7K |
| Earning Date | 02-12-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,557,500,000.00 | $11,218,000.00 |
| Revenue This Year | $1.62 | N/A |
| Revenue Next Year | $2.26 | $9.20 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $211.43 | $59.45 |
| 52 Week High | $373.69 | $99.63 |
Technical Indicators
Market Signals| Indicator | BIO | LLYVA |
|---|---|---|
| Relative Strength Index (RSI) | 58.55 | 53.10 |
| Support Level | $316.57 | $79.56 |
| Resistance Level | $328.56 | $82.69 |
| Average True Range (ATR) | 8.27 | 2.04 |
| MACD | 1.43 | 0.10 |
| Stochastic Oscillator | 78.70 | 67.85 |
Price Performance
Historical ComparisonAbout BIO Bio-Rad Laboratories Inc.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
About LLYVA Liberty Media Corporation Series A Liberty Live
Liberty Live Group would be engaged in the operations of Live Nation, and Liberty Media's planning for that group is to maximize the value of its investment in that company and the other assets attributed to the Liberty Live Group and to use the new Liberty Live common stock to make strategic acquisitions or for other capital raising initiatives.